Loading clinical trials...
Loading clinical trials...
A Prospective, Open-label, Non-interventional Post-market Study Evaluating the Performance and Safety of AnGelHA 2 Filler for Correcting Moderate to Severe Wrinkles and Folds and Facial Contour Remodeling in Routine Clinical Use.
Conditions
Locations
1
Israel
Glyance Ltd
Lod, Israel, Israel
Start Date
February 8, 2026
Primary Completion Date
March 12, 2027
Completion Date
March 12, 2027
Last Updated
April 15, 2026
NCT07255261
NCT07222397
NCT06997380
NCT06854796
NCT07367204
NCT07222176
Lead Sponsor
Glyance
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions